Tempest Therapeutics Inc (TPST) is higher by 8.83% Wednesday In Premarket Trading

Tempest Therapeutics Inc (TPST) has gained Wednesday morning, with the stock rising 8.83% in pre-market trading to 3.45. TPST's short-term technical score of 84 indicates that the stock has traded more bullishly over the last month than 84% of stocks on the market. In the Biotechnology industry, which ranks 94 out of 146 industries, the stock ranks higher than 88% of stocks. Tempest Therapeutics Inc has fallen 21.53% over the past month, closing at $4.19 on February 7. During this period of time, the stock fell as low as $3.16 and as high as $4.47. TPST has an average analyst recommendation of Strong Buy. The company has an average price target of $20.00.

TPST has an Overall Score of 60. Find out what this means to you and get the rest of the rankings on TPST!

See Full TPST Report

Tempest Therapeutics Inc has a Long-Term Technical rank of 17. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 83% of the market scoring higher. In the Biotechnology industry which is number 48 by this metric, TPST ranks better than 48% of stocks.

Important Dates for Investors in TPST:

-Tempest Therapeutics Inc is set to release earnings on 2024-03-27. Over the last 12 months, the company has reported EPS of $-2.20. -We do not have a set dividend date for Tempest Therapeutics Inc at this time. Click Here To Get The Full Report on Tempest Therapeutics Inc (TPST)